Global Radiation Ablators Market
- Report Code: HE 1055
- Publish Date: Upcoming
Radiation Ablators is a major component of Ablation Devices market.
Radiation Ablators can be segmented by Applications, Companies, MacroIndicators, Geographies and Products. Geographies covered by Radiation Ablators are North America, Europe and Asia.
Leading companies of Radiation Ablators,are Elekta, Boston Scientific, St. Jude Medical, Inc., Biosense Webster, Inc., Accuray Incorporated, Medtronic, Inc., CR Bard and Varian Medical Systems, Inc..
What makes our report unique?
- What are market estimates and forecasts; which of Radiation Ablators markets are doing well and which are not?
- What is the competitive landscape; How companies like Elekta, Boston Scientific and St. Jude Medical, Inc. doing in Radiation Ablators?
Key questions answered
- What are the market estimates and forecasts based on which the markets are doing well, and which are not?
- What is the competitive landscape?
- Who are the main players in each segment?
- What are their strategic directives, operational strengths, key selling products, and product pipelines?
- Who is doing what?
-
Audience for this report
- Radiation Ablators Companies
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 Radiation Ablators by Applications
4.1 Cancer
4.2 Cardiovascular Disorders
4.3 Ophthalmic Disorders
4.4 Gynecology & Obstetrics
4.5 Urinary Disorders
4.6 Musculoskeletal Disorders
5 Radiation Ablators by Products
5.1 Brachytherapy
5.2 Stereotactic Radiosurgery & Stereotactic Radiotherapy
5.3 Image Guided Radiation Therapy (IGRT)
6 Radiation Ablators by Geographies
6.1 North America
6.2 Europe
6.3 Asia
7 Radiation Ablators by Companies
7.1 Elekta
7.2 Boston Scientific
7.3 St. Jude Medical, Inc.
7.4 Biosense Webster, Inc.
7.5 Accuray Incorporated
7.6 Medtronic, Inc.
7.7 CR Bard
7.8 Varian Medical Systems, Inc.
Please fill in the form below to receive a free copy of the Summary of this Report
Custom Market Research Services
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Global Brachytherapy Market The global brachytherapy market was valued at $450 Million in 2013.Peers of Brachytherapy are Stereotactic Radiosurgery & Stereotactic Radiotherapy and Image Guided Radiation Therapy (IGRT) comprising respectively of the Global Radiation Ablators market. The Market is segmented on basis of products, applications and technology. Deep dive analysis of the top players of this domain, have been considered in the report. |
Upcoming |
|
|
Stereotactic Radiosurgery & Stereotactic Radiotherapy Stereotactic Radiosurgery & Stereotactic Radiotherapy and Brachytherapy and |
Upcoming |
|
|
Image Guided Radiation Therapy (IGRT) Image Guided Radiation Therapy (IGRT) and Brachytherapy and |
Upcoming |
|
|
High-Dose-Rate (HDR) brachytherapy High-Dose-Rate (HDR) brachytherapy and Pulsed-Dose-Rate brachytherapy and |
Upcoming |
|
|
Pulsed-Dose-Rate brachytherapy Pulsed-Dose-Rate brachytherapy and High-Dose-Rate (HDR) brachytherapy and |
Upcoming |
|
|
Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy and High-Dose-Rate (HDR) brachytherapy and |
Upcoming |
|
|
European Brachytherapy The European Brachytherapy Market was pegged at $50 million in 2013 and expected to be $54 million by 2018. The report “European Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The main companies operating in European Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
Asia-Pacific Brachytherapy The Asia-Pacific Radiation Ablation Market was pegged at $32 million in 2013 and expected to be $38 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Asia-Pacific brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
Americas Brachytherapy The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
9 reports |
Show
Radiation Ablators
